2 FTSE 100 stocks I’d buy today and hold forever in a Stocks and Shares ISA

These two FTSE 100 (INDEXFTSE:UKX) shares could offer high long-term returns, in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 may be facing a period of uncertainty, due to risks such as coronavirus and geopolitical uncertainty in the US and Europe. However, there are a number of large-cap shares which appear to offer good value for money at present, due to their long-term growth potential.

With that in mind, here are two stocks that could be worth buying today through a tax-efficient account such as a Stocks and Shares ISA. They appear to have favourable long-term operating environments which may catalyse their financial performances in the coming years.

GSK

The next couple of years will be a period of significant change for GSK (LSE: GSK). Its separation into two companies could create a degree of uncertainty, which may cause investor sentiment to weaken. However, the end result is set to be a more focused biopharma company, as well as a leader in consumer healthcare.

The long-term growth potential for both businesses appears to be high. A growing, ageing world population could provide rising demand for a wide range of healthcare products. This could help to stimulate the company’s bottom line following its relatively lacklustre 1% rise in earnings in the 2020 financial year.

The stock’s price-to-earnings (P/E) ratio of 14.6 suggests it currently offers a wide margin of safety. Alongside its dividend yield of 4.6%, the company could offer the chance for investors to generate improving total returns – especially as it has the potential to become leaner and more focused as two companies. As such, now could be the right time to buy a slice of the business while it appears to offer good value for money.

Segro

Another FTSE 100 company which could have a bright long-term future is real estate investment trust (REIT) Segro (LSE: SGRO). It owns a range of warehouses across the UK and Europe which have experienced high demand from online retailers in recent years.

That trend looks set to continue, with suitable large warehouses seemingly in short supply. Segro reported in its recent quarterly update that demand for its properties has been high, and that rental growth has been buoyant. This could contribute to rising profitability over the long run, while over the next two years it’s expected to post an increase in its net profit of 8% per annum.

Segro’s price-to-book (P/B) ratio of 1.5 may be substantially higher than many of its REIT sector peers. However, its stronger financial prospects and the high demand for its properties means is could be worthy of a premium valuation. The long-term growth potential of online retailing suggests further share price growth could be ahead for the company following its 40% rise over the past year.

As such, buying it today, and holding it for the long run, could be a shrewd move.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Grey cat peeking out from inside a cardboard box in a house
Investing Articles

Just released: April’s latest small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The Anglo American share price soars to £25, but I’m not selling!

On Thursday, the Anglo American share price soared after mega-miner BHP Group made an unsolicited bid for it. But I…

Read more »

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »